These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1143522)

  • 1. Proceedings: The physiological disposition of C14-verapamil in man.
    Schomerus M; Stieren B; Spiegelhalder B; Eichelbaum M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R94. PubMed ID: 1143522
    [No Abstract]   [Full Text] [Related]  

  • 2. Disposition kinetics and urinary excretion of verapamil and some of its primary metabolites after oral administration in patients with angina pectoris.
    Piotrovskii VK; Rumiantsev DO; Nikolenko SA; Riabokon OS; Metelitsa VI
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):4-11. PubMed ID: 3957489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial disposition and cardiac pharmacodynamics of verapamil in the dog.
    Keefe DL; Kates RE
    J Pharmacol Exp Ther; 1982 Jan; 220(1):91-6. PubMed ID: 7053427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drugs with first-pass elimination. Verapamil and dihydroergotamine alkaloids].
    Rietbrock N; Woodcock BG
    Internist (Berl); 1982 Nov; 23(11):610-5. PubMed ID: 6759451
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
    Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
    Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of calcium ion antagonists.
    Eichelbaum M
    Clin Invest Med; 1980; 3(1-2):13-7. PubMed ID: 7471537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetics of bromazepam in man].
    Raaflaub J; Speiser-Courvoisier J
    Arzneimittelforschung; 1974 Nov; 24(11):1841-4. PubMed ID: 4155636
    [No Abstract]   [Full Text] [Related]  

  • 8. The bioavailability of a slow-release verapamil formulation.
    Norris RJ; Muirhead DC; Christie RB; Devane JG; Bottini PB
    Br J Clin Pract Suppl; 1985 Jun; 42():9-16. PubMed ID: 3929828
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of bioavailability of verapamil by rifampin.
    Rahn KH; Mooy J; Böhm R; vd Vet A
    N Engl J Med; 1985 Apr; 312(14):920-1. PubMed ID: 3974676
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacodynamic comparison of oral and intravenous verapamil in atrial fibrillation.
    Follath F; Fromer M; Meier P; Vozeh S
    Clin Invest Med; 1980; 3(1-2):49-52. PubMed ID: 7009004
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action.
    Mikus G; Eichelbaum M; Fischer C; Gumulka S; Klotz U; Kroemer HK
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of meso-caval shunt surgery on verapamil kinetics, bioavailability and response.
    Eichelbaum M; Albrecht M; Kliems G; Schäfer K; Somogyi A
    Br J Clin Pharmacol; 1980 Nov; 10(5):527-30. PubMed ID: 7437267
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical differentiation of nifedipine and other calcium antagonists.
    Ebner F; Donath M; Rämsch KD
    Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine.
    Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N
    Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical pharmacology of calcium inhibitors].
    Singlas E; Martre H; Taburet AM
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():15-22. PubMed ID: 3937500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding.
    Mehvar R; Reynolds J
    Drug Metab Dispos; 1996 Oct; 24(10):1088-94. PubMed ID: 8894509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Disposition of propoxyphene in children.
    Wilson JT
    Acta Pharm Suec; 1974 Dec; 11(6):651-2. PubMed ID: 1136803
    [No Abstract]   [Full Text] [Related]  

  • 18. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
    Nelson WL; Olsen LD; Beitner DB; Pallow RJ
    Drug Metab Dispos; 1988; 16(2):184-8. PubMed ID: 2898330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic behavior of verapamil in man].
    Schomerus M; Eichelbaum M; Stieren B; Spiegelhalter B; Dengler HJ
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1697-9. PubMed ID: 1030083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.